OTC : NPNKF

Nippon Shinyaku Co., Ltd.

$31.4 USD

$0 (0.0%)

Volume
81
Average Volume
133.02
Market Capitalization
$2.12B
P/E Ratio
9.18
Dividend Yield
3.06%
Price Target
Year High
$38.01
Year Low
$21.00
Day High
—
Day Low
—
Payout Ratio
$0.28
Current Ratio
$4.35
Company Overview

OTC

Toru Nakai

Drug Manufacturers - Specialty & Generic

Healthcare

NPNKF

2309

JP

USD

https://www.nippon-shinyaku.co.jp

81 7 5321 1111

N/A

N/A

Liquidity Metrics

0.01

4.35

3.12

1.82

0.28

Sales & Valuation

$171.85B

1.60

0.94

11.26

359.86

Profitability

$444.19

$29.91B

17.40%

21.35%

10.94%

8.58%

P/E Metrics

9.18

-1.05

-1.05

Analyst Price Target & Rating

N/A

0/5

2 Analysts

%

Poll Results

About Nippon Shinyaku Co., Ltd. (OTC:NPNKF) Stock

Nippon Shinyaku Co., Ltd., founded in Kyoto, Japan, in 1911, operates globally as a developer, manufacturer, and distributor of pharmaceutical products and functional foods. The company is organized into two primary divisions: Pharmaceuticals and Functional Food. Within its Pharmaceutical division, Nippon Shinyaku offers an extensive range of medications to markets across Japan, Switzerland, and other international territories. These therapeutic solutions address diverse medical challenges such as urological disorders, inflammatory and allergic conditions, hematologic malignancies, cardiovascular and metabolic diseases, and gastrointestinal ailments. Key pharmaceutical offerings include Zalutia and Eviprostat for benign prostatic urinary issues; Bladderon for frequent urination; Estracyt f ... or prostate cancer; and Cialis for erectile dysfunction. Its oncology and hematology portfolio further encompasses Vidaza for myelodysplastic syndrome; Cylocide for solid tumors and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva, a humanized anti-CD20 monoclonal antibody; Defiterio for sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. The company also provides Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler for allergic rhinitis; Azunol Gargle liquid, an azulene-based gargling solution; Isobide for oral osmotic diuresis and Meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for the management of cancer and chronic pain. Beyond its existing product lines, Nippon Shinyaku actively invests in the research, development, and commercialization of new treatments within gynecology, otorhinolaryngology, and orthopedics. The Functional Food segment delivers a variety of health-oriented products, including health food ingredients, preservatives, protein preparations, supplements, and a selection of spices and condiments.

Frequently Asked Questions

What is the current Nippon Shinyaku Co., Ltd. (NPNKF) stock price?

Nippon Shinyaku Co., Ltd.(OTC:NPNKF) stock price is $31.4 in the last trading session. During the trading session, NPNKF stock reached the peak price of $38.01 while $21 was the lowest point it dropped to. The percentage change in NPNKF stock occurred in the recent session was 0.0% while the dollar amount for the price change in NPNKF stock was $0.

NPNKF's industry and sector of operation?

The OTC listed NPNKF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of NPNKF?

Masaya Toda | Head of Licensing & Alliance Division and Corporate Officer
Mitsuharu Koizumi | Head of Dir., Pers., Gen. Aff., Risk Man.,Comp. & Dig. Trans. Dept., Corp. Off. and Director
Toru Nakai | President & Representative Director
Hayato Wada | Corporate Officer & Department Manager of Kansai Business Office
Hideyuki Fujii | Accounting & Finance Department Manager

How many employees does NPNKF have?

Number of NPNKF employees currently stands at 2309. NPNKF operates from 14, Nishinosho-Monguchi-cho, Kyoto, KY 601-8550, JP.

Link for NPNKF official website?

Official Website of NPNKF is: https://www.nippon-shinyaku.co.jp

How do I contact NPNKF?

NPNKF could be contacted at phone #81 7 5321 1111 and can also be accessed through its website. NPNKF operates from 14, Nishinosho-Monguchi-cho, Kyoto, KY 601-8550, JP.

How many shares of NPNKF are traded daily?

The average number of NPNKF shares traded daily for last 3 months was 133.02.

What is the market cap of NPNKF currently?

The market value of NPNKF currently stands at $2.12B with its latest stock price at $31.4